Refining translational treatment development in fragile X syndrome: Lessons learned and future directions
Fragile X research has been very productive since the underlying genetic cause of the disease was discovered, with many studies reporting novel treatments that address neuroanatomical, electrophysiological, and behavioral features in mouse models. However, translating this to humans has proved difficult. Journal of Neurodevelopmental Disorders is proud to publish this thematic series, which examines the research to date and suggests ways to overcome some of the challenges facing Fragile X research.
This series was edited by Professor Craig Erickson (Cincinnati Children's Hospital Medical Center).